Decellularized tissue engineered constructs and tissues
CA 2419817 C · Owner: Mitchell, Shannon · Inventors: Prabhakar, Vikas; Koh, Jennifer; Mitchell, Shannon
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
New methods for producing tissue engineered constructs and engineered native tissues are disclosed. The methods include producing a tissue engineered construct bz growing cells in vitro on a substrate and then decellularizing the construct to produce a decellularized construct consisting largely of extracellular matrix components. The construct can bu used immediatley or stored unitl needed. The decellularized construct can be used for further tissue eingineering, which may include seeding the construct with cells obtained from the intended receipient of hte construct. During any of the growth phases required for production of the construct the developing , construct maz be …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 16, 2001 and granted November 18, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended August 16, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 16, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.